Dodge & Cox Stock Fund UnitedHealth Group Incorporated transactions over time
UNH
UnitedHealth Group Incorporated historical holders
total: 37
Transactions details
- Total transactions:
- 23
- New positions:
- 1
- Added:
- 8
- Reduced:
- 14
- Held since:
- 2019 Q3
- Held for:
- 28 quarters
- Latest activity:
- 2026 Q2
Dodge & Cox Stock Fund has been an institutional investor in UnitedHealth Group Incorporated (UNH) since 2019 Q3. According to 2026 Q2 report, Dodge & Cox Stock Fund holds 6,000,460 shares with a market value of roughly $2.49B representing 2.11% of their equity portfolio. The fund/company first acquired UNH in 2019 Q3, initially purchasing about 4.31M shares. Since the initial investment, Dodge & Cox Stock Fund has made 22 more transactions in this position.
Does Dodge & Cox Stock Fund still hold UNH?
Yes, Dodge & Cox Stock Fund continues to hold UnitedHealth Group Incorporated (UNH). According to their 2026 Q2 report, they maintain a position of 6,000,460 shares valued at approximately $2.49B, representing 2.11% of their equity portfolio.
When did Dodge & Cox Stock Fund first invest in UNH?
Dodge & Cox Stock Fund first invested in UnitedHealth Group Incorporated (UNH) in 2019 Q3 at the reported quarter-end price of $217.32 per share, acquiring 4,312,460 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for UNH?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for UnitedHealth Group Incorporated (UNH) is approximately $279.24 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $279.24
- Weighted AVG sell price:
- $361.39
UNH transactions history by Dodge & Cox Stock Fund
23 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.11%
|
6,000,460
|
$415.63
|
$2,493,971,190
|
-7.72% (-501,800)
|
-0.18%
|
|
2026 Q1
|
1.54%
|
6,502,260
|
$270.59
|
$1,759,446,533
|
+3.55% (+222,800)
|
+0.05%
|
|
2025 Q4
|
1.73%
|
6,279,460
|
$330.11
|
$2,072,912,541
|
-3.57% (-232,300)
|
-0.06%
|
|
2025 Q3
|
1.87%
|
6,511,760
|
$345.30
|
$2,248,510,728
|
+8.62% (+517,000)
|
+0.15%
|
|
2025 Q2
|
1.59%
|
5,994,760
|
$311.97
|
$1,870,185,277
|
+117.41% (+3,237,400)
|
+0.86%
|
|
2024 Q4
|
1.25%
|
2,757,360
|
$505.86
|
$1,394,838,130
|
+4.43% (+116,900)
|
+0.05%
|
|
2024 Q3
|
1.33%
|
2,640,460
|
$584.68
|
$1,543,824,153
|
-0.56% (-14,800)
|
-0.01%
|
|
2024 Q1
|
1.20%
|
2,655,260
|
$494.70
|
$1,313,557,122
|
+18.29% (+410,500)
|
+0.19%
|
|
2023 Q4
|
1.17%
|
2,244,760
|
$526.47
|
$1,181,798,797
|
-0.86% (-19,500)
|
-0.01%
|
|
2023 Q3
|
1.24%
|
2,264,260
|
$504.19
|
$1,141,617,249
|
-0.38% (-8,600)
|
-0%
|
|
2023 Q2
|
1.18%
|
$480.64
|
+0.37% (+8,300)
|
|||
|
2022 Q4
|
1.36%
|
$530.18
|
-6.15% (-148,300)
|
|||
|
2022 Q3
|
1.54%
|
$505.04
|
-2.97% (-73,900)
|
|||
|
2022 Q2
|
1.50%
|
$513.63
|
-3.72% (-96,100)
|
|||
|
2021 Q3
|
1.11%
|
$390.74
|
+0.92% (+23,500)
|
|||
|
2021 Q2
|
1.15%
|
$400.44
|
-4.13% (-110,300)
|
|||
|
2021 Q1
|
1.22%
|
$372.07
|
-9.93% (-294,300)
|
|||
|
2020 Q4
|
1.47%
|
$350.68
|
-22.15% (-843,200)
|
|||
|
2020 Q3
|
1.95%
|
$311.77
|
-2.02% (-78,600)
|
|||
|
2020 Q2
|
1.92%
|
$294.95
|
-21.42% (-1,058,900)
|
|||
|
2020 Q1
|
2.40%
|
$249.38
|
-0.39% (-19,300)
|
|||
|
2019 Q4
|
1.96%
|
$293.98
|
+15.11% (+651,500)
|
|||
|
2019 Q3
|
1.35%
|
$217.32
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.